Editorial
Nature Biotechnology 25, 363 (2007)
doi:10.1038/nbt0407-363
Sacrificing the cash cow
Abstract
In view of concerns about safety, could Amgen's aggressive promotion of erythropoietin (EPO) have jeopardized its billion-dollar franchise?
Extra navigation
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Instrumentation Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Senior Research Fellow - Atlantic Ocean Circulation and Climate
- University of Southampton
- Southampton / Hampshire United Kingdom
ADVERTISEMENT
